Financials
Income statement
Fiscal date | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 4.4B | 3.6B | 3.4B | 2.9B |
Cost of revenue | 2.8B | 2.2B | 2.1B | 1.9B |
Gross profit | 1.7B | 1.4B | 1.3B | 1.0B |
Operating expense | ||||
Research & development | 167.4M | 150.5M | 141.9M | 137.8M |
Selling general and admin | 281.2M | 249.4M | 227.5M | 211.2M |
Other operating expenses | — | — | — | — |
Operating income | 1.2B | 970.1M | 951.6M | 657.8M |
Non operating interest income | ||||
Income | 11.2M | 14.6M | 36.8M | 34.1M |
Expense | 548K | 3.4M | 5.3M | 4.4M |
Other income expense | — | — | — | — |
Pretax income | 1.3B | 994.4M | 1.1B | 871.9M |
Tax provision | 224.4M | 219.7M | 202.8M | 183.3M |
Net income | 1.1B | 774.7M | 853.1M | 688.6M |
Basic EPS | — | 5.4 | 6.0 | 5.1 |
Diluted EPS | — | 5.4 | 6.0 | 5.0 |
Basic average shares | — | 142.9M | 141.5M | 140.5M |
Diluted average shares | — | 142.9M | 141.5M | 141.2M |
EBITDA | 1.5B | 1.2B | 1.2B | 1.0B |
Net income from continuing op. | 1.3B | 994.4M | 1.1B | 871.9M |
Minority interests | -4.0M | -4.3M | -1.5M | 22.4M |
Preferred stock dividends | 0 | 0 | 0 | 0 |